Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Status in Breast Cancer: A Focus on Group 4 Using the 2018 ASCO/CAP HER2 Testing Guideline

被引：0
|
作者：
Hoda, Raza [1 ]
Bowman, Anita [2 ]
Zehir, Ahmet [1 ]
Brogi, Edi [1 ,3 ]
Ladanyi, Marc [1 ]
Arcila, Maria [1 ]
Wen, Hannah [1 ]
Ross, Dara [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Yeadon, PA USA
[3] Weill Cornell Med Coll, New York, NY USA
来源：
LABORATORY INVESTIGATION | 2020年 / 100卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
185
引用
收藏
页码：175 / 177
页数：3
相关论文
共 50 条
  • [21] Impact of 2013 ASCO/CAP Guideline Recommendations on HER2 FISH Testing in Breast Cancer
    Marketkar, Shivali
    Singh, Kamaljeet
    Jackson, Cynthia
    Hart, Jesse
    Resnick, Murray B.
    Wang, Yihong
    MODERN PATHOLOGY, 2016, 29 : 498A - 498A
  • [22] Impact of 2013 ASCO/CAP Guideline Recommendations on HER2 FISH Testing in Breast Cancer
    Marketkar, Shivali
    Singh, Kamaljeet
    Jackson, Cynthia
    Hart, Jesse
    Resnick, Murray B.
    Wang, Yihong
    LABORATORY INVESTIGATION, 2016, 96 : 498A - 498A
  • [23] Reassessment of HER2 Status in Invasive Micropapillary Carcinoma of the Breast - Recommendations for Improvement of 2023 ASCO/CAP Guideline on HER2 Testing
    Li, Y.
    Zhang, M.
    Yue, M.
    Yuan, X.
    Liu, C.
    Li, X.
    Liu, Y.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 104 - 105
  • [24] Impact of the Updated Guidelines on Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer
    Kim, Min Chong
    Kang, Su Hwan
    Choi, Jung Eun
    Bae, Young Kyung
    JOURNAL OF BREAST CANCER, 2020, 23 (05) : 484 - 497
  • [25] Human epidermal growth factor receptor 2 (HER2) status in breast cancer: practice points and challenges
    Laokulrath, Natthawadee
    Gudi, Mihir
    Salahuddin, Syed Ahmed
    Chong, Angela Phek Yoon
    Ding, Cristine
    Iqbal, Jabed
    Leow, Wei Qiang
    Tan, Benjamin Yongcheng
    Tse, Gary
    Rakha, Emad
    Tan, Puay Hoon
    HISTOPATHOLOGY, 2024, 85 (03) : 371 - 382
  • [26] Draft recommendations for human epidermal growth factor receptor 2 (HER2) testing in breast cancer will decrease HER2 positivity rates
    Johnson, Eric
    Gulbahce, Evin
    CANCER RESEARCH, 2018, 78 (04)
  • [27] Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+Invasive Breast Cancer
    Yamada, Mai
    Kubo, Makoto
    Yamamoto, Hidetaka
    Yamashita, Nami
    Kai, Masaya
    Zaguirre, Karen
    Kaneshiro, Kazuhisa
    Shimazaki, Akiko
    Hayashi, Saori
    Kawaji, Hitomi
    Mori, Masaki
    Oda, Yoshinao
    Nakamura, Masafumi
    ANTICANCER RESEARCH, 2021, 41 (08) : 4143 - 4149
  • [28] Comparative analysis of human epidermal growth factor receptor 2 (HER2) testing in breast cancer according to 2007 and 2013 American Society of Clinical Oncology / College of American Pathologist guideline recommendations (ASCO/CAP)
    Wernicke, A.
    De la Iglesia, P.
    Garcia Rivello, H.
    VIRCHOWS ARCHIV, 2018, 473 : S31 - S31
  • [29] Genomic alterations in human epidermal growth factor receptor 2 (HER2/ERBB2) in head and neck squamous cell carcinoma
    Chung, Christine H.
    Germain, Alexis
    Subramaniam, Rathan M.
    Heilmann, Andreas M.
    Fedorchak, Kyle
    Ali, Siraj M.
    Miller, Vincent A.
    Palermo, Robert A.
    Fakhry, Carole
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (01): : E15 - E19
  • [30] Targeted Next-Generation Sequencing Enables Reliable Detection of HER2 (ERBB2) Status in Breast Cancer and Provides Ancillary Information of Clinical Relevance
    Pfarr, Nicole
    Penzel, Roland
    Endris, Volker
    Lier, Clemens
    Flechtenmacher, Christa
    Volckmar, Anna-Lena
    Kirchner, Martina
    Budczies, Jan
    Leichsenring, Jonas
    Herpel, Esther
    Noske, Aurelia
    Weichert, Wilko
    Schneeweiss, Andreas
    Schirmacher, Peter
    Sinn, Hans-Peter
    Stenzinger, Albrecht
    GENES CHROMOSOMES & CANCER, 2017, 56 (04): : 255 - 265
12345